Cesare Saltini
- Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective studyBy Marco Mura, Maria A. Porretta, Elena Bargagli, Gianluigi Sergiacomi, Maurizio Zompatori, Nicola Sverzellati, Amedeo Taglieri, Fabrizio Mezzasalma, Paola Rottoli, Cesare Saltini and Paola RoglianiMarco MuraMaria A. PorrettaElena BargagliGianluigi SergiacomiMaurizio ZompatoriNicola SverzellatiAmedeo TaglieriFabrizio MezzasalmaPaola RottoliCesare SaltiniPaola Rogliani
- Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosisBy Paola Spitalieri, Maria Chiara Quitadamo, Augusto Orlandi, Lorenzo Guerra, Emiliano Giardina, Valeria Casavola, Cesare Saltini, Giuseppe Novelli and Federica SangiuoloPaola Spitalieri1Department of Biopathology, Tor Vergata University of Rome, Rome, RM, ItalyMaria Chiara Quitadamo2Department of Genetics, IRCCS Centro Neurolesi Bonino Pulejo, Messina, ME, ItalyAugusto Orlandi1Department of Biopathology, Tor Vergata University of Rome, Rome, RM, ItalyLorenzo Guerra3Department of General Environmental Physiology, Bari University, Bari, BA, ItalyEmiliano Giardina1Department of Biopathology, Tor Vergata University of Rome, Rome, RM, ItalyValeria Casavola3Department of General Environmental Physiology, Bari University, Bari, BA, ItalyCesare Saltini4Internal Medicine, University of Roma 2Tor Vergata", Roma, RM, ItalyGiuseppe Novelli1Department of Biopathology, Tor Vergata University of Rome, Rome, RM, ItalyFederica Sangiuolo1Department of Biopathology, Tor Vergata University of Rome, Rome, RM, Italy
- BAL markers of alveolar/capillary abnormality in IPFBy Ermanno Puxeddu, Alessia Comandini, Paola Rogliani, Assunta Porretta, Francesco Cavalli and Cesare SaltiniErmanno Puxeddu1Respiratory Medicine, University of "Tor Vergata", Rome, ItalyAlessia Comandini1Respiratory Medicine, University of "Tor Vergata", Rome, ItalyPaola Rogliani1Respiratory Medicine, University of "Tor Vergata", Rome, ItalyAssunta Porretta1Respiratory Medicine, University of "Tor Vergata", Rome, ItalyFrancesco Cavalli1Respiratory Medicine, University of "Tor Vergata", Rome, ItalyCesare Saltini1Respiratory Medicine, University of "Tor Vergata", Rome, Italy
- Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian regionBy Maria Assunta Porretta, Lisa Bauleo, Angelo Coppola, Gianluigi Sergiacomi, Maria Cristina Zappa, Stefano Carlone, Salvatore Mariotta, Paolo Palange, Salvatore Valente, Gabriella Pezzuto, Nera Agabiti, Marco Pallante, Ermanno Puxeddu and Cesare SaltiniMaria Assunta Porretta1UOC Malattie Respiratorie, Policlinico Universitario "Tor Vergata", Roma, ItalyLisa Bauleo2Dipartimento Di Epidemiologia, Servizio Sanitario Regionale, Lazio, Roma, ItalyAngelo Coppola1UOC Malattie Respiratorie, Policlinico Universitario "Tor Vergata", Roma, ItalyGianluigi Sergiacomi3Department of Radiology, Policlinico Universitario "Tor Vergata", Roma, ItalyMaria Cristina Zappa4UOC Pneumologia, Ospedale Sandro Pertini, Roma, ItalyStefano Carlone5UOC Pneumologia, Ospedale San Giovanni Addolorata, Roma, ItalySalvatore Mariotta6UOC Pneumologia, Policlinico Universitario Sant'Andrea, Università "La Sapienza", Roma, ItalyPaolo Palange7UOC Medicina, Policlinico Universitario Umberto I, Università "La Sapienza", Roma, ItalySalvatore Valente8UOC Pneumologia, Policlinico Universitario Agostino Gemelli, Università Cattolica, Roma, ItalyGabriella Pezzuto1UOC Malattie Respiratorie, Policlinico Universitario "Tor Vergata", Roma, ItalyNera Agabiti2Dipartimento Di Epidemiologia, Servizio Sanitario Regionale, Lazio, Roma, ItalyMarco Pallante9Department of Biomedicine, University of Roma "Tor Vergata", Rome, ItalyErmanno Puxeddu9Department of Biomedicine, University of Roma "Tor Vergata", Rome, ItalyCesare Saltini1UOC Malattie Respiratorie, Policlinico Universitario "Tor Vergata", Roma, Italy
- Improved performances of the Quantiferon-TB in tube assay with novel mycobacterium tuberculosis specific antigenic peptidesBy Monica Losi, Ashley Knights, Francesca Mariani, Alfonso Altieri, Gregorino Paone, Vittorio Colizzi, Cesare Saltini, Jeff Boyle and Massimo AmicosanteMonica Losi1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyAshley Knights2Research and Development, Cellestis - Qiagen, Chadstone, AustraliaFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Pulmonary Diseases, University of Rome "La Sapienza, Rome, ItalyVittorio Colizzi6Biology, University of Rome "Tor Vergata", Rome, ItalyCesare Saltini1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyJeff Boyle2Research and Development, Cellestis - Qiagen, Chadstone, AustraliaMassimo Amicosante1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
- HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosisBy Federica Sangiuolo, Ermanno Puxeddu, Gabriella Pezzuto, Francesco Cavalli, Giuliana Longo, Alessia Comandini, Donato Di Pierro, Marco Pallante, Gianluigi Sergiacomi, Giovanni Simonetti, Maurizio Zompatori, Augusto Orlandi, Andrea Magrini, Massimo Amicosante, Francesca Mariani, Monica Losi, Daniela Fraboni, Alberto Bisetti and Cesare SaltiniArticle | Published in 2014 in European Respiratory JournalFederica Sangiuolo1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy11Both authors contributed equallyErmanno Puxeddu1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy11Both authors contributed equallyGabriella Pezzuto2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, ItalyFrancesco Cavalli3Postgraduate School in Respiratory Diseases, University of Roma Tor Vergata, Rome, ItalyGiuliana Longo1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyAlessia Comandini2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, ItalyDonato Di Pierro4Dept of Clinical Science and Translation Medicine, University of Roma Tor Vergata, Rome, ItalyMarco Pallante1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyGianluigi Sergiacomi5Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University Hospital Tor Vergata, Rome, ItalyGiovanni Simonetti5Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University Hospital Tor Vergata, Rome, ItalyMaurizio Zompatori6Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Bologna, Bologna, ItalyAugusto Orlandi7Dept of Anatomic Pathology, University of Roma Tor Vergata, Rome, ItalyAndrea Magrini1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyMassimo Amicosante1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyFrancesca Mariani8Institute Cell Biology and Neurobiology, National Research Council, Monterotondo Scalo, ItalyMonica Losi2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, ItalyDaniela Fraboni9Dept of Laboratory Medicine, University Hospital Tor Vergata, Rome, ItalyAlberto Bisetti10University of Roma La Sapienza, Rome, ItalyCesare Saltini1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, Italy3Postgraduate School in Respiratory Diseases, University of Roma Tor Vergata, Rome, Italy
- HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosisBy Federica Sangiuolo, Ermanno Puxeddu, Gabriella Pezzuto, Francesco Cavalli, Giuliana Longo, Alessia Comandini, Donato Di Pierro, Marco Pallante, Gianluigi Sergiacomi, Giovanni Simonetti, Maurizio Zompatori, Augusto Orlandi, Andrea Magrini, Massimo Amicosante, Francesca Mariani, Monica Losi, Daniela Fraboni, Alberto Bisetti and Cesare SaltiniArticle | Published in 2014 in European Respiratory JournalFederica Sangiuolo1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy11Both authors contributed equallyErmanno Puxeddu1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy11Both authors contributed equallyGabriella Pezzuto2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, ItalyFrancesco Cavalli3Postgraduate School in Respiratory Diseases, University of Roma Tor Vergata, Rome, ItalyGiuliana Longo1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyAlessia Comandini2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, ItalyDonato Di Pierro4Dept of Clinical Science and Translation Medicine, University of Roma Tor Vergata, Rome, ItalyMarco Pallante1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyGianluigi Sergiacomi5Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University Hospital Tor Vergata, Rome, ItalyGiovanni Simonetti5Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University Hospital Tor Vergata, Rome, ItalyMaurizio Zompatori6Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Bologna, Bologna, ItalyAugusto Orlandi7Dept of Anatomic Pathology, University of Roma Tor Vergata, Rome, ItalyAndrea Magrini1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyMassimo Amicosante1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, ItalyFrancesca Mariani8Institute Cell Biology and Neurobiology, National Research Council, Monterotondo Scalo, ItalyMonica Losi2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, ItalyDaniela Fraboni9Dept of Laboratory Medicine, University Hospital Tor Vergata, Rome, ItalyAlberto Bisetti10University of Roma La Sapienza, Rome, ItalyCesare Saltini1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, Italy3Postgraduate School in Respiratory Diseases, University of Roma Tor Vergata, Rome, Italy
- Late-breaking abstract: Efficacy of pirfenidone for idiopathic pulmonary fibrosis (IPF): An Italian real life studyBy Sergio Harari, Valeria Giunta, Carlo Albera, Carlo Vancheri, Venerino Poletti, Alberto Pesci, Fabrizio Luppi, Cesare Saltini, Carlo Agostini, Paola Rottoli, Alfredo Sebastiani, Alessandro Sanduzzi, Antonella Caminati, Rossana Della Porta, Gian Piero Bandelli, Silvia Puglisi, Sara Tomassetti, Alice Biffi, Cerri Stefania, Alessia Mari, Francesco Cinetto, Francesca Tirelli, Gianfranco Farinelli, Marialuisa Bocchino and Marco ConfalonieriSergio Harari1Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria-Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe MultiMedica, Milan, ItalyValeria Giunta1Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria-Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe MultiMedica, Milan, ItalyCarlo Albera2Department of Clinical and Biological Sciences, Center for Rare Pulmonary Disease, San Luigi Gonzaga Medical School, Turin, ItalyCarlo Vancheri3Regional Centre for Rare Lung Disease, University of Catania, Catania, ItalyVenerino Poletti4Pulmonary Unit, GB Morgagni Hospital, Forlì, ItalyAlberto Pesci5Clinica Pneumologica, Department of Health Science, University of Milan Bicocca, AO San Gerardo, Monza, ItalyFabrizio Luppi6Unit of Respiratory Disease, University Hospital, Modena, ItalyCesare Saltini7Respiratory Diseases Unit, Department of Medicine, "Tor Vergata" University Hospital, Roma, ItalyCarlo Agostini8Department of Clinical and Experimental Medicine, University of Padua, Padua, ItalyPaola Rottoli9Respiratory Diseases and Lung Transplant Unit, Department of Internal and Specialistic Medicine, AOUS, Siena, ItalyAlfredo Sebastiani10Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Roma, ItalyAlessandro Sanduzzi11Division of Pneumology, Department of Respiratory Diseases, High Speciality Hospital "V.Monaldi" Naples and University of Naples Federico II, Naples, ItalyAntonella Caminati1Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria-Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe MultiMedica, Milan, ItalyRossana Della Porta12Department of Pneumology, University Hospital of Trieste, Trieste, ItalyGian Piero Bandelli2Department of Clinical and Biological Sciences, Center for Rare Pulmonary Disease, San Luigi Gonzaga Medical School, Turin, ItalySilvia Puglisi3Regional Centre for Rare Lung Disease, University of Catania, Catania, ItalySara Tomassetti4Pulmonary Unit, GB Morgagni Hospital, Forlì, ItalyAlice Biffi5Clinica Pneumologica, Department of Health Science, University of Milan Bicocca, AO San Gerardo, Monza, ItalyCerri Stefania6Unit of Respiratory Disease, University Hospital, Modena, ItalyAlessia Mari7Respiratory Diseases Unit, Department of Medicine, "Tor Vergata" University Hospital, Roma, ItalyFrancesco Cinetto8Department of Clinical and Experimental Medicine, University of Padua, Padua, ItalyFrancesca Tirelli9Respiratory Diseases and Lung Transplant Unit, Department of Internal and Specialistic Medicine, AOUS, Siena, ItalyGianfranco Farinelli10Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Roma, ItalyMarialuisa Bocchino11Division of Pneumology, Department of Respiratory Diseases, High Speciality Hospital "V.Monaldi" Naples and University of Naples Federico II, Naples, ItalyMarco Confalonieri12Department of Pneumology, University Hospital of Trieste, Trieste, Italy
- HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosisBy Federica Sangiuolo, Ermanno Puxeddu, Gabriella Pezzuto, Francesco Cavalli, Giuliana Longo, Alessia Comandini, Donato Di Pierro, Marco Pallante, Gianluigi Sergiacomi, Giovanni Simonetti, Maurizio Zompatori, Augusto Orlandi, Andrea Magrini, Massimo Amicosante, Francesca Mariani, Monica Losi, Daniela Fraboni, Alberto Bisetti and Cesare SaltiniFederica Sangiuolo1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.11Both authors contributed equally.Ermanno Puxeddu1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.11Both authors contributed equally.Gabriella Pezzuto2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, Italy.Francesco Cavalli3Postgraduate School in Respiratory Diseases, University of Roma Tor Vergata, Rome, Italy.Giuliana Longo1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.Alessia Comandini2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, Italy.Donato Di Pierro4Dept of Clinical Science and Translation Medicine, University of Roma Tor Vergata, Rome, Italy.Marco Pallante1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.Gianluigi Sergiacomi5Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University Hospital Tor Vergata, Rome, Italy.Giovanni Simonetti5Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiation Therapy, University Hospital Tor Vergata, Rome, Italy.Maurizio Zompatori6Dept of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University of Bologna, Bologna, Italy.Augusto Orlandi7Dept of Anatomic Pathology, University of Roma Tor Vergata, Rome, Italy.Andrea Magrini1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.Massimo Amicosante1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.Francesca Mariani8Institute Cell Biology and Neurobiology, National Research Council, Monterotondo Scalo, Italy.Monica Losi2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, Italy.Daniela Fraboni9Dept of Laboratory Medicine, University Hospital Tor Vergata, Rome, Italy.Alberto Bisetti10University of Roma La Sapienza, Rome, Italy.Cesare Saltini1Dept of Biomedicine and Prevention, University of Roma Tor Vergata, Rome, Italy.2Division of Respiratory Diseases, University Hospital Tor Vergata, Rome, Italy.3Postgraduate School in Respiratory Diseases, University of Roma Tor Vergata, Rome, Italy.
- Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosisBy Carmela Gallo, Alessia Del Duca, Monica Losi, Alba Grifoni, Roberta Bernardini, Alfonso Altieri, Gregorino Paone, Maurizio Mattei, Cesare Saltini and Massimo AmicosanteCarmela Gallo1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyAlessia Del Duca1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyMonica Losi1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyAlba Grifoni3R&D, ProxAgen Ltd., Sofia, BulgariaRoberta Bernardini2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyAlfonso Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Pulmonary Diseases, University of Rome "La Sapienza", Rome, ItalyMaurizio Mattei2Animal Technology Station, University of Rome "Tor Vergata", Rome, ItalyCesare Saltini1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, ItalyMassimo Amicosante1Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy3R&D, ProxAgen Ltd., Sofia, Bulgaria
- A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPFBy Ermanno Puxeddu, Gabirella Pezzuto, Marco Pallante, Josuel Ora, Angelo Coppola, Alessia Mari, Silvia Portalone, Francesco Cavalli, Giuseppe Liotta, Leonardo Palombi and Cesare SaltiniErmanno Puxeddu1Biomedicine and Prevention, University of Tor Vergata, Rome, ItalyGabirella Pezzuto2Respiratory Disease Unit, Tor Vergata University Hospital, Rome, ItalyMarco Pallante1Biomedicine and Prevention, University of Tor Vergata, Rome, ItalyJosuel Ora2Respiratory Disease Unit, Tor Vergata University Hospital, Rome, ItalyAngelo Coppola2Respiratory Disease Unit, Tor Vergata University Hospital, Rome, ItalyAlessia Mari2Respiratory Disease Unit, Tor Vergata University Hospital, Rome, ItalySilvia Portalone2Respiratory Disease Unit, Tor Vergata University Hospital, Rome, ItalyFrancesco Cavalli2Respiratory Disease Unit, Tor Vergata University Hospital, Rome, ItalyGiuseppe Liotta1Biomedicine and Prevention, University of Tor Vergata, Rome, ItalyLeonardo Palombi1Biomedicine and Prevention, University of Tor Vergata, Rome, ItalyCesare Saltini1Biomedicine and Prevention, University of Tor Vergata, Rome, Italy2Respiratory Disease Unit, Tor Vergata University Hospital, Rome, Italy
- QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigensBy Monica Losi, Ashley J. Knights, Francesca Mariani, Alfonso M. Altieri, Gregorino Paone, Andre G. Loxton, Novel N. Chegou, John Kenneth, Mario G. Alma, Vittorio Colizzi, Gerhard Walzl, Cesare Saltini, Jeff Boyle and Massimo AmicosanteArticle | Published in 2015 in European Respiratory JournalMonica Losi1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyAshley J. Knights2QIAGEN Sciences LLC, Germantown, MD, USAFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso M. Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Dept of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, University of Rome “La Sapienza”, Rome, ItalyAndre G. Loxton6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaNovel N. Chegou6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaJohn Kenneth7Division of Infectious Diseases, St John's Research Institute, St John's National Academy of Health Sciences, Bangalore, IndiaMario G. Alma4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyVittorio Colizzi8Dept of Biology, University of Rome “Tor Vergata”, Rome, ItalyGerhard Walzl6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaCesare Saltini1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyJeff Boyle2QIAGEN Sciences LLC, Germantown, MD, USAMassimo Amicosante1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, Italy
- QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigensBy Monica Losi, Ashley J. Knights, Francesca Mariani, Alfonso M. Altieri, Gregorino Paone, Andre G. Loxton, Novel N. Chegou, John Kenneth, Mario G. Alma, Vittorio Colizzi, Gerhard Walzl, Cesare Saltini, Jeff Boyle and Massimo AmicosanteMonica Losi1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyAshley J. Knights2QIAGEN Sciences LLC, Germantown, MD, USAFrancesca Mariani3Institute of Cell Biology and Neurobiology, National Research Council, Rome, ItalyAlfonso M. Altieri4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyGregorino Paone5Dept of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, University of Rome “La Sapienza”, Rome, ItalyAndre G. Loxton6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaNovel N. Chegou6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaJohn Kenneth7Division of Infectious Diseases, St John's Research Institute, St John's National Academy of Health Sciences, Bangalore, IndiaMario G. Alma4Broncopneumologia e Tisiologia, Azienda Ospedaliera San Camillo Forlanini, Rome, ItalyVittorio Colizzi8Dept of Biology, University of Rome “Tor Vergata”, Rome, ItalyGerhard Walzl6SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaCesare Saltini1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, ItalyJeff Boyle2QIAGEN Sciences LLC, Germantown, MD, USAMassimo Amicosante1Dept of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, Italy
- α1-Antitrypsin DeficiencyEdited by Pavel Strnad, Mark L. Brantly and Robert BalsBook | Published in 2019DOI: 10.1183/2312508X.erm8519ISBN (electronic): 978-1-84984-109-2Pavel StrnadMark L. Brantly
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.